Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense

Steeve Boulant (1) , Adriana Forero (2, 3) , Deanna M Santer (4) , Achille Broggi (5)

1 University of Florida, College of Medicine, Gainesville
2 Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, USA
3 The James Comprehensive Cancer Center, The Ohio State University
4 University of Manitoba [Winnipeg]
5 CIML - Centre d'Immunologie de Marseille - Luminy

Keywords: interferon IFN-lambda antiviral IBD infection mucosae IFN-l4 vaccine; interferon; IFN-lambda; antiviral; IBD; infection; mucosae; IFN-l4; vaccine

Domains: Life Sciences [q-bio]

Steeve Boulant, Adriana Forero, Deanna M Santer, Achille Broggi. Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense. Frontiers in Immunology, 2022, 13, ⟨10.3389/fimmu.2022.1030812⟩. ⟨hal-03951832⟩